Limitations, agreements, and source contact

Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · Source last updated 2014-04-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restriction Type

LTE60

restrictive Agreement

true

point Of Contact

email

furym@mskcc.org

organization

Memorial Sloan-Kettering Cancer Center

phone

646-888-4233

title

Matthew Fury, MD

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice